Global Companion Diagnostics Market Outlook 2021: Global Opportunity and Demand Analysis, Market Forecast, 2022-2030
DESCRIPTION
TABLE OF CONTENTS
RELATED REPORTS
SAMPLE REQUEST
REVIEWS
DESCRIPTION
The growth of the worldwide companion diagnostics market is often attributed to the rising specialization in personalized medicine and, therefore, the co-development of drug and diagnostic technologies. Additionally, rising cases of adverse drug reactions related to drugs, due to their lack of efficacy, drive the need for companion diagnostics.The companion diagnostics market is predicted to reach USD 6.8 billion by 2028, up from USD 3.7 billion in 2019, at a CAGR of 13.9% during the forecast period of 2019 to 2028.
The growing need for targeted therapy will drive market growth.
With advances in genetic sequencing and genomics, it is now widely believed that drugs can work differently in different individuals. A better understanding of the genetic characteristics or biomarkers of an individual can promote the practice of administering ""the right drug, at the right time, at the right dose, for the proper person."" Pharmaceutical and biopharmaceutical companies are continuously attempting to implement patient-selection diagnostic frameworks within the earlier stages of drug development to supply targeted therapies to the proper candidate. This further supports the expansion of the companion diagnostics market.
One of the main factors driving the expansion of the companion diagnostics market is the increasing demand for personalized medicines and awareness about their equivalents among the population. With companies increasing their collaborations for better biomarkers and diagnostics to specialize in cost regulations, a large number of opportunities for its applications in indications such as cancer, cardiovascular, and neurological disorders have arisen.
Pharmaceutical and biopharmaceutical companies make crucial contributions to the growth of the global companion diagnostics market.
Pharmaceutical and biopharmaceutical companies are estimated to be the most important end-users of companion diagnostics in 2019. Pharmaceutical and biopharmaceutical companies are expected to account for the most important share of the companion diagnostics market in 2019. The large share of this segment can be majorly attributed to the extensive usage of companion diagnostics in these industries due to their growing prominence in drug development and the increasing importance of companion diagnostic biomarkers. The increasing demand for personalized medicine as well as the high demand for targeted therapies for various diseases and disorders are also expected to drive the demand and uptake of companion diagnostics among pharmaceutical and biopharmaceutical companies.
By technology, the polymerase chain reaction (PCR) segment will account for the most important share of the companion diagnostics market in 2019. The polymerase chain reaction segment is predicted to dominate the companion diagnostics market in 2019. The large share of this segment is often attributed to the convenience of use and widespread availability of PCR kits and reagents in companion diagnostic testing, growing applications of PCR in the high-throughput detection of mutants with a limited or low allele frequency of genes, and the high turnaround time of PCR as compared to other technologies.
During the forecast period, the Asia-Pacific market is expected to grow the most rapidly.
The companion diagnostics market within APAC is estimated to grow at the very best CAGR during the forecast period. The high incidence of cancer, increasing proteomics and genomics research, growing research funding, rising investments by pharmaceutical and biotechnology companies, and growing awareness about personalized therapeutics in several APAC countries are expected to drive the growth of the APAC market.
Players Will Concentrate on the Companion Diagnostics Market
The companion diagnostics market is dominated by a couple of globally established players, like
Roche Diagnostics Inc.
Agilent Technologies, Inc.
Thermo Fisher Scientific
Abbott Laboratories, Inc.
F. Hoffmann-La Roche AG is an abbreviation for F. Hoffmann-La Roche AG.
Agilent Technologies, Inc.
QIAGEN N.V.
Almac Group
Danaher Corporation
Illumina, Inc.
bioMrieux SA
The Reports Purpose
By Application
Cardiovascular
Neurological Conditions
Cancer
By End-user
Pharmaceutical and biopharmaceutical firms
Reference Laboratories
CROs
Others (doctors, hospitals, academic medical centers, and payers)
By Product
Assay kits and reagents
Services & Software
Market for Companion Diagnostics
By Region
North America
Europe
Asia and the Pacific
Rest of the World
The Most Important Reasons to Buy This Report
1. It provides a technological development map over time to understand the growth rate of the industry.
2. The report offers a dynamic method for analyzing various factors that drive or restrain the growth of the market.
3. It renders a definite analysis of changing competitive dynamics.
4. It builds a seven-year estimate based on how the market is predicted to grow.
The growing need for targeted therapy will drive market growth.
With advances in genetic sequencing and genomics, it is now widely believed that drugs can work differently in different individuals. A better understanding of the genetic characteristics or biomarkers of an individual can promote the practice of administering ""the right drug, at the right time, at the right dose, for the proper person."" Pharmaceutical and biopharmaceutical companies are continuously attempting to implement patient-selection diagnostic frameworks within the earlier stages of drug development to supply targeted therapies to the proper candidate. This further supports the expansion of the companion diagnostics market.
One of the main factors driving the expansion of the companion diagnostics market is the increasing demand for personalized medicines and awareness about their equivalents among the population. With companies increasing their collaborations for better biomarkers and diagnostics to specialize in cost regulations, a large number of opportunities for its applications in indications such as cancer, cardiovascular, and neurological disorders have arisen.
Pharmaceutical and biopharmaceutical companies make crucial contributions to the growth of the global companion diagnostics market.
Pharmaceutical and biopharmaceutical companies are estimated to be the most important end-users of companion diagnostics in 2019. Pharmaceutical and biopharmaceutical companies are expected to account for the most important share of the companion diagnostics market in 2019. The large share of this segment can be majorly attributed to the extensive usage of companion diagnostics in these industries due to their growing prominence in drug development and the increasing importance of companion diagnostic biomarkers. The increasing demand for personalized medicine as well as the high demand for targeted therapies for various diseases and disorders are also expected to drive the demand and uptake of companion diagnostics among pharmaceutical and biopharmaceutical companies.
By technology, the polymerase chain reaction (PCR) segment will account for the most important share of the companion diagnostics market in 2019. The polymerase chain reaction segment is predicted to dominate the companion diagnostics market in 2019. The large share of this segment is often attributed to the convenience of use and widespread availability of PCR kits and reagents in companion diagnostic testing, growing applications of PCR in the high-throughput detection of mutants with a limited or low allele frequency of genes, and the high turnaround time of PCR as compared to other technologies.
During the forecast period, the Asia-Pacific market is expected to grow the most rapidly.
The companion diagnostics market within APAC is estimated to grow at the very best CAGR during the forecast period. The high incidence of cancer, increasing proteomics and genomics research, growing research funding, rising investments by pharmaceutical and biotechnology companies, and growing awareness about personalized therapeutics in several APAC countries are expected to drive the growth of the APAC market.
Players Will Concentrate on the Companion Diagnostics Market
The companion diagnostics market is dominated by a couple of globally established players, like
Roche Diagnostics Inc.
Agilent Technologies, Inc.
Thermo Fisher Scientific
Abbott Laboratories, Inc.
F. Hoffmann-La Roche AG is an abbreviation for F. Hoffmann-La Roche AG.
Agilent Technologies, Inc.
QIAGEN N.V.
Almac Group
Danaher Corporation
Illumina, Inc.
bioMrieux SA
The Reports Purpose
By Application
Cardiovascular
Neurological Conditions
Cancer
By End-user
Pharmaceutical and biopharmaceutical firms
Reference Laboratories
CROs
Others (doctors, hospitals, academic medical centers, and payers)
By Product
Assay kits and reagents
Services & Software
Market for Companion Diagnostics
By Region
North America
Europe
Asia and the Pacific
Rest of the World
The Most Important Reasons to Buy This Report
1. It provides a technological development map over time to understand the growth rate of the industry.
2. The report offers a dynamic method for analyzing various factors that drive or restrain the growth of the market.
3. It renders a definite analysis of changing competitive dynamics.
4. It builds a seven-year estimate based on how the market is predicted to grow.
TABLE OF CONTENTS
Chapter 1 Overview And Scope
1.1 Market Vision
1.1.1 Market Definition
1.1.2 Market Scope
1.2 Market Segmentation
Chapter 2 Our Research Practice
2.1 Our Research Methodology
2.2 Data Triangulation
2.3 Data Sources
2.4 Assumptions for the study
2.5 Approach Adopted
Chapter 3 Executive Summary
3.1 Market Snapshot
3.2 Regional Snapshot
3.3 Segment Summary
Chapter 4 Covid-19 Impact Analysis
4.1 Overview
4.2 Prevalence analysis
4.3 Key Factor Impact Analysis
Chapter 5 Global Companion diagnostics Market Forces
5.1 Whats Driving the Market
5.2 Porters Five Forces Analysis
5.2.1 Power of Suppliers
5.2.2 Threats From New Entrants
5.2.3 Power of Buyer
5.2.4 Threat From Substitute Product
5.2.5 Degree of Competition
Chapter 6 Global Companion diagnostics Market -Industry Snapshots
6.1 Overview
6.1.1 Global Companion diagnostics Market Value, 2019 - 2028, (US$ Bn)
6.2 Market Overview
6.2.1 Drivers Analysis
6.2.2 Restraint/Challenges analysis
6.2.3 Opportunity Analysis
6.3 Supply Chain/Value Chain Analysis
6.4 Market SWOT Analysis
Chapter 7 Global Companion diagnostics Market Analysis, by Application
7.1 Overview
7.2 Key Findings for Companion diagnostics Market- By Type
7.2.1 Companion diagnostics Market- Cardiovascular
7.2.2 Companion diagnostics Market- Neurological Diseases
7.2.3 Companion diagnostics Market- Cancer
Chapter 8 Global Companion diagnostics Market Analysis, by End user
8.1 Overview
8.2 Key Findings for Companion diagnostics Market- By Product Type
8.2.1 Companion diagnostics Market- Pharmaceutical & Biopharmaceutical Companies
Companion diagnostics market by End user Type 1, 2019 - 2028 (USD Million)
8.2.2 Companion diagnostics Market- Reference Laboratories
Companion diagnostics market by End user Type 2, 2019 - 2028 (USD Million)
8.2.3 Companion diagnostics Market- CROs
8.2.4 Companion diagnostics Market- Others
Chapter 9 Global Companion diagnostics Market Analysis, by Product
9.1 Overview
9.2 Key Findings for Companion diagnostics Market- By End User
9.2.1 Companion diagnostics Market- Assay kits & Reagents
Companion diagnostics market by End User 1, 2019 - 2028 (USD Million)
9.2.2 Companion diagnostics Market- Software & Services
Companion diagnostics market by End User 2, 2019 - 2028 (USD Million)
9.2.3 Companion diagnostics Market- Companion diagnostics Market
Chapter 10 Companion diagnostics Market Analysis by Region
10.1 Key Findings for Companion diagnostics Market- By region
10.2 Overview
10.2.1 Global Companion diagnostics Market Analysis, By Type, 2019 - 2028
10.2.2 Global Companion diagnostics Market Analysis, By Product Type, 2019 - 2028
10.2.3 Global Companion diagnostics Market Analysis, By End User, 2019 - 2028
10.3 Companion diagnostics Market North America
10.3.1 Overview
10.3.2 U.S.
10.3.3 Canada
10.3.4 Mexico
10.3.5 North America Market, By Type
10.3.6 North America Market, By Product Type
10.3.7 North America Market, By End User
10.4 Companion diagnostics Market Europe
10.4.1 Overview
10.4.2 Germany
10.4.3 United Kingdom
10.4.4 France
10.4.5 Italy
10.4.6 Rest Of Europe
10.4.7 Europe Market, By Type
10.4.8 Europe Market, By Product Type
10.4.9 Europe market by, End User
10.5 Companion diagnostics Market Asia Pacific
10.5.1 Overview
10.5.2 China
10.5.3 Japan
10.5.4 India
10.5.5 Rest of APAC
10.5.6 Asia Pacific Market, By Type
10.5.7 Asia Pacific Market, By Product Type
10.5.8 Asia Pacific Market, By End User
10.6 Companion diagnostics Market Rest Of World
10.6.1 Overview
10.6.2 Middle East & Africa (MEA)
10.6.3 Latin America
10.6.4 Rest Of World
10.6.5 Latin America, Middle East and Africa Market, By Type
10.6.6 Latin America, Middle East and Africa Market, By Product Type
10.6.7 Latin America, Middle East and Africa Market, By End User
Chapter 11 Market Competition Analysis
11.1 Market Share/Positioning Analysis
11.1.1 Market Positioning of Key Vendors, 2019
11.1.2 Key Strategies Adopted by the Leading Players
11.1.3 Recent Developments
Chapter 12 Company Profiles- Snapshot
12.1 BioMrieux SA
12.1.1 Business Fundamentals
12.1.2 Financial Snapshots
12.1.3 Product Portfolio
12.1.4 Recent Developments
12.2 Roche Diagnostics
12.3 Agilent Technologies
12.4 Thermo Fisher
12.5 Abbott Laboratories
12.6 F. Hoffmann-La Roche AG
12.7 Agilent Technologies, Inc
12.8 QIAGEN N.V
12.9 Almac Group
12.10 Danaher Corporatio
12.11 Illumina, Inc
*More than 10 Companies are profiled in this Research Report*
*Financials would be provided on a best efforts basis for private companies"
Chapter 13 Appendix
TABLE 2 Companion diagnostics market by Application 2, 2019 - 2028 (USD Million)
TABLE 3 Companion diagnostics market by Application 3, 2019 - 2028 (USD Million)
TABLE 4 Companion diagnostics market by End user Type 3, 2019 - 2028 (USD Million)
TABLE 5 Companion diagnostics market by End user Type 4, 2019 - 2028 (USD Million)
TABLE 6 Companion diagnostics market by End User 3, 2019 - 2028 (USD Million)
TABLE 7 Global Companion diagnostics Market Value, By Type, 2019 - 2028 (US$ Bn)
TABLE 8 Global Companion diagnostics Market Value, By Product Type, 2019 - 2028 (US$ Bn)
TABLE 9 Global Companion diagnostics Market Value, By End User, 2019 - 2028 (US$ Bn)
TABLE 10 Companion diagnostics Market Analysis by North America (USD Million), 2019 - 2028
TABLE 11 U.S. Companion diagnostics Market, 2019 - 2028 (USD Million)
TABLE 12 U.S. Companion diagnostics Market, By Type, 2019 - 2028 (USD Million)
TABLE 13 U.S. Companion diagnostics Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 14 U.S. Companion diagnostics Market, By End User, 2019 - 2028 (USD Million)
TABLE 15 Canada Companion diagnostics Market, 2019 - 2028 (USD Million)
TABLE 16 Canada Companion diagnostics Market, By Type, 2019 - 2028 (USD Million)
TABLE 17 Canada Companion diagnostics Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 18 Canada Companion diagnostics Market, By End User, 2019 - 2028 (USD Million)
TABLE 19 Mexico Companion diagnostics Market, 2019 - 2028 (USD Million)
TABLE 20 Mexico Companion diagnostics Market, By Type, 2019 - 2028 (USD Million)
TABLE 21 Mexico Companion diagnostics Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 22 Mexico Companion diagnostics Market, By End User, 2019 - 2028 (USD Million)
TABLE 23 Companion diagnostics Market Analysis by Europe (USD Million), 2019 - 2028
TABLE 24 Germany Companion diagnostics Market, 2019 - 2028 (USD Million)
TABLE 25 Germany Companion diagnostics Market, By Type, 2019 - 2028 (USD Million)
TABLE 26 Germany Companion diagnostics Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 27 Germany Companion diagnostics Market, By End User, 2019 - 2028 (USD Million)
TABLE 28 United Kingdom Companion diagnostics Market, 2019 - 2028 (USD Million)
TABLE 29 United Kingdom Companion diagnostics Market, By Type, 2019 - 2028 (USD Million)
TABLE 30 United Kingdom Companion diagnostics Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 31 United Kingdom Companion diagnostics Market, By End User, 2019 - 2028 (USD Million)
TABLE 32 France Companion diagnostics Market, 2019 - 2028 (USD Million)
TABLE 33 France Companion diagnostics Market, By Type, 2019 - 2028 (USD Million)
TABLE 34 France Companion diagnostics Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 35 France Companion diagnostics Market, By End User, 2019 - 2028 (USD Million)
TABLE 36 Italy Companion diagnostics Market, 2019 - 2028 (USD Million)
TABLE 37 Italy Companion diagnostics Market, By Type, 2019 - 2028 (USD Million)
TABLE 38 Italy Companion diagnostics Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 39 Italy Companion diagnostics Market, By End User, 2019 - 2028 (USD Million)
TABLE 40 Rest Of Europe Companion diagnostics Market, 2019 - 2028 (USD Million)
TABLE 41 Rest Of Europe Companion diagnostics Market, By Type, 2019 - 2028 (USD Million)
TABLE 42 Rest Of Europe Companion diagnostics Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 43 Rest of Europe Companion diagnostics Market, By End User, 2019 - 2028 (USD Million)
TABLE 44 Companion diagnostics Market Analysis by Asia Pacific (USD Million), 2019 - 2028
TABLE 45 China Companion diagnostics Market, 2019 - 2028 (USD Million)
TABLE 46 China Companion diagnostics Market, By Type, 2019 - 2028 (USD Million)
TABLE 47 China Companion diagnostics Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 48 China Companion diagnostics Market, By End User, 2019 - 2028 (USD Million)
TABLE 49 Japan Companion diagnostics Market, 2019 - 2028 (USD Million)
TABLE 50 Japan Companion diagnostics Market, By Type, 2019 - 2028 (USD Million)
TABLE 51 Japan Companion diagnostics Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 52 Japan Companion diagnostics Market, By End User, 2019 - 2028 (USD Million)
TABLE 53 India Companion diagnostics Market, 2019 - 2028 (USD Million)
TABLE 54 India Companion diagnostics Market, By Type, 2019 - 2028 (USD Million)
TABLE 55 India Companion diagnostics Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 56 India Companion diagnostics Market, By End User, 2019 - 2028 (USD Million)
TABLE 57 Rest of APAC Companion diagnostics Market, 2019 - 2028 (USD Million)
TABLE 58 Rest of APAC Companion diagnostics Market, By Type, 2019 - 2028 (USD Million)
TABLE 59 Rest of APAC Companion diagnostics Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 60 Rest of APAC Companion diagnostics Market, By End User, 2019 - 2028 (USD Million)
TABLE 61 Companion diagnostics Market Analysis by Rest Of World (USD Million), 2019 - 2028
TABLE 62 Middle East & Africa (MEA) Companion diagnostics Market, 2019 - 2028 (USD Million)
TABLE 63 Middle East & Africa (MEA) Companion diagnostics Market, By Type, 2019 - 2028 (USD Million)
TABLE 64 Middle East & Africa (MEA) Companion diagnostics Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 65 Middle East & Africa (MEA) Market, By End User, 2019 - 2028 (USD Million)
TABLE 66 Latin America Companion diagnostics Market, 2019 - 2028 (USD Million)
TABLE 67 Latin America Companion diagnostics Market, By Type, 2019 - 2028 (USD Million)
TABLE 68 Latin America Companion diagnostics Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 69 Latin America Companion diagnostics Market, By End User, 2019 - 2028 (USD Million)
TABLE 70 Rest Of World Companion diagnostics Market, 2019 - 2028 (USD Million)
TABLE 71 Rest Of World Companion diagnostics Market, By Type, 2019 - 2028 (USD Million)
TABLE 72 Rest Of World Companion diagnostics Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 73 Rest Of World Companion diagnostics Market, By End User, 2019 - 2028 (USD Million)
FIG. 2 Global Companion diagnostics Market: Research Methodology
FIG. 3 Top-Down and Bottom Up Approach
FIG. 4 Market Snapshot
FIG. 5 Porters Five Forces Analysis
FIG. 6 Global Companion diagnostics Market Value, 2019 - 2028, (US$ Bn)
FIG. 7 Supply Chain/Value Chain Analysis
FIG. 8 Global Companion diagnostics Market Value Contribution, By Type, 2019 & 2026 (%)
FIG. 9 Global Companion diagnostics Market Value Contribution, By Product Type, 2019 & 2026 (%)
FIG. 10 Global Companion diagnostics Market Value Contribution, By End User, 2019 & 2026 (%)
FIG. 11 Global Companion diagnostics Market Value, 2019 - 2028, (US$ Bn)
FIG. 12 North America Companion diagnostics Market Value, 2019 - 2028, (US$ Bn)
FIG. 13 Companion diagnostics Market Segment 1 North America
FIG. 14 Companion diagnostics Market Segment 2 North America
FIG. 15 Companion diagnostics Market Segment 3 North America
FIG. 16 Companion diagnostics U.S. outlook, 2019 & 2026
FIG. 17 Companion diagnostics Canada outlook, 2019 & 2026
FIG. 18 Companion diagnostics Mexico outlook, 2019 & 2026
FIG. 19 Europe Companion diagnostics Market Value, 2019 - 2028, (US$ Bn)
FIG. 20 Companion diagnostics Market Segment 1 Europe
FIG. 21 Companion diagnostics Market Segment 2 Europe
FIG. 22 Companion diagnostics Market Segment 3 Europe
FIG. 23 Companion diagnostics Germany outlook, 2019 & 2026
FIG. 24 Companion diagnostics United Kingdom outlook, 2019 & 2026
FIG. 25 Companion diagnostics France outlook, 2019 & 2026
FIG. 26 Companion diagnostics Italy outlook, 2019 & 2026
FIG. 27 Companion diagnostics Rest Of Europe outlook, 2019 & 2026
FIG. 28 Asia Pacific Companion diagnostics Market Value, 2019 - 2028, (US$ Bn)
FIG. 29 Companion diagnostics Market Segment 1 Asia Pacific
FIG. 30 Companion diagnostics Market Segment 2 Asia Pacific
FIG. 31 Companion diagnostics Market Segment 2 Asia Pacific
FIG. 32 Companion diagnostics China outlook, 2019 & 2026
FIG. 33 Companion diagnostics Japan outlook, 2019 & 2026
FIG. 34 Companion diagnostics India outlook, 2019 & 2026
FIG. 35 Companion diagnostics Rest of APAC outlook, 2019 & 2026
FIG. 36 Rest Of World Companion diagnostics Market Value, 2019 - 2028, (US$ Bn)
FIG. 37 Companion diagnostics Market Segment 1 Rest Of World
FIG. 38 Companion diagnostics Market Segment 2 Rest Of World
FIG. 39 Companion diagnostics Market Segment 3 Rest Of World
FIG. 40 Companion diagnostics Middle East & Africa (MEA) outlook, 2019 & 2026
FIG. 41 Companion diagnostics Latin America outlook, 2019 & 2026
FIG. 42 Companion diagnostics Rest Of World outlook, 2019 & 2026
Companies Mentioned
BioMrieux SA
Roche Diagnostics
Agilent Technologies
Thermo Fisher
Abbott Laboratories
F. Hoffmann-La Roche AG
Agilent Technologies, Inc
QIAGEN N.V
Almac Group
Danaher Corporatio
Illumina, Inc
1.1 Market Vision
1.1.1 Market Definition
1.1.2 Market Scope
1.2 Market Segmentation
Chapter 2 Our Research Practice
2.1 Our Research Methodology
2.2 Data Triangulation
2.3 Data Sources
2.4 Assumptions for the study
2.5 Approach Adopted
Chapter 3 Executive Summary
3.1 Market Snapshot
3.2 Regional Snapshot
3.3 Segment Summary
Chapter 4 Covid-19 Impact Analysis
4.1 Overview
4.2 Prevalence analysis
4.3 Key Factor Impact Analysis
Chapter 5 Global Companion diagnostics Market Forces
5.1 Whats Driving the Market
5.2 Porters Five Forces Analysis
5.2.1 Power of Suppliers
5.2.2 Threats From New Entrants
5.2.3 Power of Buyer
5.2.4 Threat From Substitute Product
5.2.5 Degree of Competition
Chapter 6 Global Companion diagnostics Market -Industry Snapshots
6.1 Overview
6.1.1 Global Companion diagnostics Market Value, 2019 - 2028, (US$ Bn)
6.2 Market Overview
6.2.1 Drivers Analysis
6.2.2 Restraint/Challenges analysis
6.2.3 Opportunity Analysis
6.3 Supply Chain/Value Chain Analysis
6.4 Market SWOT Analysis
Chapter 7 Global Companion diagnostics Market Analysis, by Application
7.1 Overview
7.2 Key Findings for Companion diagnostics Market- By Type
7.2.1 Companion diagnostics Market- Cardiovascular
7.2.2 Companion diagnostics Market- Neurological Diseases
7.2.3 Companion diagnostics Market- Cancer
Chapter 8 Global Companion diagnostics Market Analysis, by End user
8.1 Overview
8.2 Key Findings for Companion diagnostics Market- By Product Type
8.2.1 Companion diagnostics Market- Pharmaceutical & Biopharmaceutical Companies
Companion diagnostics market by End user Type 1, 2019 - 2028 (USD Million)
8.2.2 Companion diagnostics Market- Reference Laboratories
Companion diagnostics market by End user Type 2, 2019 - 2028 (USD Million)
8.2.3 Companion diagnostics Market- CROs
8.2.4 Companion diagnostics Market- Others
Chapter 9 Global Companion diagnostics Market Analysis, by Product
9.1 Overview
9.2 Key Findings for Companion diagnostics Market- By End User
9.2.1 Companion diagnostics Market- Assay kits & Reagents
Companion diagnostics market by End User 1, 2019 - 2028 (USD Million)
9.2.2 Companion diagnostics Market- Software & Services
Companion diagnostics market by End User 2, 2019 - 2028 (USD Million)
9.2.3 Companion diagnostics Market- Companion diagnostics Market
Chapter 10 Companion diagnostics Market Analysis by Region
10.1 Key Findings for Companion diagnostics Market- By region
10.2 Overview
10.2.1 Global Companion diagnostics Market Analysis, By Type, 2019 - 2028
10.2.2 Global Companion diagnostics Market Analysis, By Product Type, 2019 - 2028
10.2.3 Global Companion diagnostics Market Analysis, By End User, 2019 - 2028
10.3 Companion diagnostics Market North America
10.3.1 Overview
10.3.2 U.S.
10.3.3 Canada
10.3.4 Mexico
10.3.5 North America Market, By Type
10.3.6 North America Market, By Product Type
10.3.7 North America Market, By End User
10.4 Companion diagnostics Market Europe
10.4.1 Overview
10.4.2 Germany
10.4.3 United Kingdom
10.4.4 France
10.4.5 Italy
10.4.6 Rest Of Europe
10.4.7 Europe Market, By Type
10.4.8 Europe Market, By Product Type
10.4.9 Europe market by, End User
10.5 Companion diagnostics Market Asia Pacific
10.5.1 Overview
10.5.2 China
10.5.3 Japan
10.5.4 India
10.5.5 Rest of APAC
10.5.6 Asia Pacific Market, By Type
10.5.7 Asia Pacific Market, By Product Type
10.5.8 Asia Pacific Market, By End User
10.6 Companion diagnostics Market Rest Of World
10.6.1 Overview
10.6.2 Middle East & Africa (MEA)
10.6.3 Latin America
10.6.4 Rest Of World
10.6.5 Latin America, Middle East and Africa Market, By Type
10.6.6 Latin America, Middle East and Africa Market, By Product Type
10.6.7 Latin America, Middle East and Africa Market, By End User
Chapter 11 Market Competition Analysis
11.1 Market Share/Positioning Analysis
11.1.1 Market Positioning of Key Vendors, 2019
11.1.2 Key Strategies Adopted by the Leading Players
11.1.3 Recent Developments
Chapter 12 Company Profiles- Snapshot
12.1 BioMrieux SA
12.1.1 Business Fundamentals
12.1.2 Financial Snapshots
12.1.3 Product Portfolio
12.1.4 Recent Developments
12.2 Roche Diagnostics
12.3 Agilent Technologies
12.4 Thermo Fisher
12.5 Abbott Laboratories
12.6 F. Hoffmann-La Roche AG
12.7 Agilent Technologies, Inc
12.8 QIAGEN N.V
12.9 Almac Group
12.10 Danaher Corporatio
12.11 Illumina, Inc
*More than 10 Companies are profiled in this Research Report*
*Financials would be provided on a best efforts basis for private companies"
Chapter 13 Appendix
List Of Tables
TABLE 1 Companion diagnostics market by Application 1, 2019 - 2028 (USD Million)TABLE 2 Companion diagnostics market by Application 2, 2019 - 2028 (USD Million)
TABLE 3 Companion diagnostics market by Application 3, 2019 - 2028 (USD Million)
TABLE 4 Companion diagnostics market by End user Type 3, 2019 - 2028 (USD Million)
TABLE 5 Companion diagnostics market by End user Type 4, 2019 - 2028 (USD Million)
TABLE 6 Companion diagnostics market by End User 3, 2019 - 2028 (USD Million)
TABLE 7 Global Companion diagnostics Market Value, By Type, 2019 - 2028 (US$ Bn)
TABLE 8 Global Companion diagnostics Market Value, By Product Type, 2019 - 2028 (US$ Bn)
TABLE 9 Global Companion diagnostics Market Value, By End User, 2019 - 2028 (US$ Bn)
TABLE 10 Companion diagnostics Market Analysis by North America (USD Million), 2019 - 2028
TABLE 11 U.S. Companion diagnostics Market, 2019 - 2028 (USD Million)
TABLE 12 U.S. Companion diagnostics Market, By Type, 2019 - 2028 (USD Million)
TABLE 13 U.S. Companion diagnostics Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 14 U.S. Companion diagnostics Market, By End User, 2019 - 2028 (USD Million)
TABLE 15 Canada Companion diagnostics Market, 2019 - 2028 (USD Million)
TABLE 16 Canada Companion diagnostics Market, By Type, 2019 - 2028 (USD Million)
TABLE 17 Canada Companion diagnostics Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 18 Canada Companion diagnostics Market, By End User, 2019 - 2028 (USD Million)
TABLE 19 Mexico Companion diagnostics Market, 2019 - 2028 (USD Million)
TABLE 20 Mexico Companion diagnostics Market, By Type, 2019 - 2028 (USD Million)
TABLE 21 Mexico Companion diagnostics Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 22 Mexico Companion diagnostics Market, By End User, 2019 - 2028 (USD Million)
TABLE 23 Companion diagnostics Market Analysis by Europe (USD Million), 2019 - 2028
TABLE 24 Germany Companion diagnostics Market, 2019 - 2028 (USD Million)
TABLE 25 Germany Companion diagnostics Market, By Type, 2019 - 2028 (USD Million)
TABLE 26 Germany Companion diagnostics Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 27 Germany Companion diagnostics Market, By End User, 2019 - 2028 (USD Million)
TABLE 28 United Kingdom Companion diagnostics Market, 2019 - 2028 (USD Million)
TABLE 29 United Kingdom Companion diagnostics Market, By Type, 2019 - 2028 (USD Million)
TABLE 30 United Kingdom Companion diagnostics Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 31 United Kingdom Companion diagnostics Market, By End User, 2019 - 2028 (USD Million)
TABLE 32 France Companion diagnostics Market, 2019 - 2028 (USD Million)
TABLE 33 France Companion diagnostics Market, By Type, 2019 - 2028 (USD Million)
TABLE 34 France Companion diagnostics Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 35 France Companion diagnostics Market, By End User, 2019 - 2028 (USD Million)
TABLE 36 Italy Companion diagnostics Market, 2019 - 2028 (USD Million)
TABLE 37 Italy Companion diagnostics Market, By Type, 2019 - 2028 (USD Million)
TABLE 38 Italy Companion diagnostics Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 39 Italy Companion diagnostics Market, By End User, 2019 - 2028 (USD Million)
TABLE 40 Rest Of Europe Companion diagnostics Market, 2019 - 2028 (USD Million)
TABLE 41 Rest Of Europe Companion diagnostics Market, By Type, 2019 - 2028 (USD Million)
TABLE 42 Rest Of Europe Companion diagnostics Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 43 Rest of Europe Companion diagnostics Market, By End User, 2019 - 2028 (USD Million)
TABLE 44 Companion diagnostics Market Analysis by Asia Pacific (USD Million), 2019 - 2028
TABLE 45 China Companion diagnostics Market, 2019 - 2028 (USD Million)
TABLE 46 China Companion diagnostics Market, By Type, 2019 - 2028 (USD Million)
TABLE 47 China Companion diagnostics Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 48 China Companion diagnostics Market, By End User, 2019 - 2028 (USD Million)
TABLE 49 Japan Companion diagnostics Market, 2019 - 2028 (USD Million)
TABLE 50 Japan Companion diagnostics Market, By Type, 2019 - 2028 (USD Million)
TABLE 51 Japan Companion diagnostics Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 52 Japan Companion diagnostics Market, By End User, 2019 - 2028 (USD Million)
TABLE 53 India Companion diagnostics Market, 2019 - 2028 (USD Million)
TABLE 54 India Companion diagnostics Market, By Type, 2019 - 2028 (USD Million)
TABLE 55 India Companion diagnostics Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 56 India Companion diagnostics Market, By End User, 2019 - 2028 (USD Million)
TABLE 57 Rest of APAC Companion diagnostics Market, 2019 - 2028 (USD Million)
TABLE 58 Rest of APAC Companion diagnostics Market, By Type, 2019 - 2028 (USD Million)
TABLE 59 Rest of APAC Companion diagnostics Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 60 Rest of APAC Companion diagnostics Market, By End User, 2019 - 2028 (USD Million)
TABLE 61 Companion diagnostics Market Analysis by Rest Of World (USD Million), 2019 - 2028
TABLE 62 Middle East & Africa (MEA) Companion diagnostics Market, 2019 - 2028 (USD Million)
TABLE 63 Middle East & Africa (MEA) Companion diagnostics Market, By Type, 2019 - 2028 (USD Million)
TABLE 64 Middle East & Africa (MEA) Companion diagnostics Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 65 Middle East & Africa (MEA) Market, By End User, 2019 - 2028 (USD Million)
TABLE 66 Latin America Companion diagnostics Market, 2019 - 2028 (USD Million)
TABLE 67 Latin America Companion diagnostics Market, By Type, 2019 - 2028 (USD Million)
TABLE 68 Latin America Companion diagnostics Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 69 Latin America Companion diagnostics Market, By End User, 2019 - 2028 (USD Million)
TABLE 70 Rest Of World Companion diagnostics Market, 2019 - 2028 (USD Million)
TABLE 71 Rest Of World Companion diagnostics Market, By Type, 2019 - 2028 (USD Million)
TABLE 72 Rest Of World Companion diagnostics Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 73 Rest Of World Companion diagnostics Market, By End User, 2019 - 2028 (USD Million)
List Of Figures
FIG. 1 Global Companion diagnostics : Market SegmentationFIG. 2 Global Companion diagnostics Market: Research Methodology
FIG. 3 Top-Down and Bottom Up Approach
FIG. 4 Market Snapshot
FIG. 5 Porters Five Forces Analysis
FIG. 6 Global Companion diagnostics Market Value, 2019 - 2028, (US$ Bn)
FIG. 7 Supply Chain/Value Chain Analysis
FIG. 8 Global Companion diagnostics Market Value Contribution, By Type, 2019 & 2026 (%)
FIG. 9 Global Companion diagnostics Market Value Contribution, By Product Type, 2019 & 2026 (%)
FIG. 10 Global Companion diagnostics Market Value Contribution, By End User, 2019 & 2026 (%)
FIG. 11 Global Companion diagnostics Market Value, 2019 - 2028, (US$ Bn)
FIG. 12 North America Companion diagnostics Market Value, 2019 - 2028, (US$ Bn)
FIG. 13 Companion diagnostics Market Segment 1 North America
FIG. 14 Companion diagnostics Market Segment 2 North America
FIG. 15 Companion diagnostics Market Segment 3 North America
FIG. 16 Companion diagnostics U.S. outlook, 2019 & 2026
FIG. 17 Companion diagnostics Canada outlook, 2019 & 2026
FIG. 18 Companion diagnostics Mexico outlook, 2019 & 2026
FIG. 19 Europe Companion diagnostics Market Value, 2019 - 2028, (US$ Bn)
FIG. 20 Companion diagnostics Market Segment 1 Europe
FIG. 21 Companion diagnostics Market Segment 2 Europe
FIG. 22 Companion diagnostics Market Segment 3 Europe
FIG. 23 Companion diagnostics Germany outlook, 2019 & 2026
FIG. 24 Companion diagnostics United Kingdom outlook, 2019 & 2026
FIG. 25 Companion diagnostics France outlook, 2019 & 2026
FIG. 26 Companion diagnostics Italy outlook, 2019 & 2026
FIG. 27 Companion diagnostics Rest Of Europe outlook, 2019 & 2026
FIG. 28 Asia Pacific Companion diagnostics Market Value, 2019 - 2028, (US$ Bn)
FIG. 29 Companion diagnostics Market Segment 1 Asia Pacific
FIG. 30 Companion diagnostics Market Segment 2 Asia Pacific
FIG. 31 Companion diagnostics Market Segment 2 Asia Pacific
FIG. 32 Companion diagnostics China outlook, 2019 & 2026
FIG. 33 Companion diagnostics Japan outlook, 2019 & 2026
FIG. 34 Companion diagnostics India outlook, 2019 & 2026
FIG. 35 Companion diagnostics Rest of APAC outlook, 2019 & 2026
FIG. 36 Rest Of World Companion diagnostics Market Value, 2019 - 2028, (US$ Bn)
FIG. 37 Companion diagnostics Market Segment 1 Rest Of World
FIG. 38 Companion diagnostics Market Segment 2 Rest Of World
FIG. 39 Companion diagnostics Market Segment 3 Rest Of World
FIG. 40 Companion diagnostics Middle East & Africa (MEA) outlook, 2019 & 2026
FIG. 41 Companion diagnostics Latin America outlook, 2019 & 2026
FIG. 42 Companion diagnostics Rest Of World outlook, 2019 & 2026
Companies Mentioned
BioMrieux SA
Roche Diagnostics
Agilent Technologies
Thermo Fisher
Abbott Laboratories
F. Hoffmann-La Roche AG
Agilent Technologies, Inc
QIAGEN N.V
Almac Group
Danaher Corporatio
Illumina, Inc
RELATED REPORTS
2024 Global Hepatitis Diagnostic Testing Markers Supplier Shares and Strategies Volume and Sales Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Procedures--Hospitals Blood Banks Commercial Labs POC Locations
2024 Global Hepatitis Diagnostic Testing for 10 Markers: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Procedures--Hospitals, Blood Banks, Commercial Labs, POC Locations The
View Report2024 Global PSA Testing Market Supplier Shares and Strategies Volume and Sales Segment Forecasts Emerging Opportunities
2024 Global PSA Testing Market: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Opportunities This unique report from provides information and analysis not available from any
View ReportGlobal Companion Animal Specialty Drugs Market Research Report
In the context of China-US trade war and COVID-19 epidemic, it will have a big influence on this market. Companion Animal Specialty Drugs Report by Material, Application, and Geography
View ReportGlobal Companion Animal Healthcare Market 2022 - Snapshot
The global companion animal healthcare market is expected to increase by USD 10 billion, at a compound annual growth rate (CAGR) of 7.4% from 2022 to 2028, according to the
View ReportSAMPLE REQUEST
Fill The Form For Sample Request
REVIEWS
